Quarry LP’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MLTX
BI
DTC
CAM
MB
WAM
LGM
Quarry LP's MLTX Position: Q1 2026 in Review
Quarry LP opened a new position in MoonLake Immunotherapeutics (MLTX) in Q1 2026: 21,250 shares worth $396K. The stake represents 0.07% of the portfolio and ranks #193 among its holdings. This is a return to the name: Quarry LP previously reported a position in MLTX as recently as Q3 2025.
Quarry LP first reported a position in MLTX in Q4 2023 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold MLTX as of Q1 2026.
- Quarry LP held 21,250 shares of MoonLake Immunotherapeutics worth $396K as of Q1 2026.
- MoonLake Immunotherapeutics was a new Quarry LP position in Q1 2026.
- MoonLake Immunotherapeutics made up 0.07% of Quarry LP's portfolio in Q1 2026, its #193 holding.
- Quarry LP first reported a position in MoonLake Immunotherapeutics in Q4 2023 and has held it in 7 quarters since.
- 147 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q1 2026.
Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.